Related references
Note: Only part of the references are listed.Clinical and Molecular Characterization of Patients with Fructose 1,6-Bisphosphatase Deficiency
Niu Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Regulation of hepatic glucose metabolism in health and disease
Max C. Petersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis
Jin Dai et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Unraveling the Regulation of Hepatic Metabolism by Insulin
Paul M. Titchenell et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer
Yifeng Liu et al.
TUMOR BIOLOGY (2017)
FBP1 expression is associated with basal-like breast carcinoma
Lei Shi et al.
ONCOLOGY LETTERS (2017)
MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation
X. Jin et al.
ONCOGENESIS (2017)
Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
Jing Yang et al.
SCIENTIFIC REPORTS (2017)
Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction
Xin Jin et al.
CANCER RESEARCH (2017)
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
Anna Karpathakis et al.
CLINICAL CANCER RESEARCH (2016)
Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells
Juan Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer
Kaichun Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma
Hidenari Hirata et al.
CANCER RESEARCH (2016)
CRTC2 Is a Coactivator of GR and Couples GR and CREB in the Regulation of Hepatic Gluconeogenesis
Micah J. Hill et al.
MOLECULAR ENDOCRINOLOGY (2016)
Rapamycin and fructose-1,6-bisphosphate reduce the HEPG2. cell proliferation via increase of free radicals and apoptosis
Elisa Feller Gocalves da Silva et al.
ONCOLOGY REPORTS (2016)
A summary of molecular genetic findings in fructose-1,6-bisphosphatase deficiency with a focus on a common long-range deletion and the role of MLPA analysis
Rene Santer et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma
Xiang-Hui Ning et al.
ONCOLOGY LETTERS (2016)
The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients
Sheng-Sen Chen et al.
SCIENTIFIC REPORTS (2016)
T-to-R switch of muscle fructose-1,6-bisphosphatase involves fundamental changes of secondary and quaternary structure
Jakub Barciszewski et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2016)
Bortezomib for the treatment of mantle cell lymphoma: an update
Bryan Hambley et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2016)
Altered oxidative stress and carbohydrate metabolism in canine mammary tumors
K. Jayasri et al.
VETERINARY WORLD (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer's Fuel Choice: New Flavors for a Picky Eater
Gina M. DeNicola et al.
MOLECULAR CELL (2015)
Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations
Bradley A. Webb et al.
NATURE (2015)
Epithelial-mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation
Linna Li et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Transcriptional and Chromatin Regulation during Fasting - The Genomic Era
Ida Goldstein et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling
Xinqun Chai et al.
SCIENTIFIC REPORTS (2015)
Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer
Henrik J. Johansson et al.
CLINICAL PROTEOMICS (2015)
Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain
Jinyu Chen et al.
CANCER RESEARCH (2015)
Determination of Protein-Ligand Binding Constants of a Cooperatively Regulated Tetrameric Enzyme Using Electrospray Mass Spectrometry
Dragana Cubrilovic et al.
ACS CHEMICAL BIOLOGY (2014)
Follow the ATP: Tumor Energy Production: A Perspective
Bryan T. Oronsky et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
Emerging Potential of Therapeutic Targeting of Ubiquitin-Specific Proteases in the Treatment of Cancer
Anupama Pal et al.
CANCER RESEARCH (2014)
Modulating effects of hesperidin on key carbohydrate-metabolizing enzymes, lipid profile, and membrane-bound adenosine triphosphatases against 7,12-dimethylbenz(a)anthracene-induced breast carcinogenesis
N. Nandakumar et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Steven E. Kahn et al.
LANCET (2014)
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li et al.
NATURE (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Chenfang Dong et al.
CANCER CELL (2013)
Increased Apoptosis Induction in Hepatocellular Carcinoma by a Novel Tumor-Targeted TRAIL Fusion Protein Combined With Bortezomib
Kristin Wahl et al.
HEPATOLOGY (2013)
Identification of proteomic signatures associated with lung cancer and COPD
M. D. Pastor et al.
JOURNAL OF PROTEOMICS (2013)
Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells
He Li et al.
MOLECULAR CANCER (2013)
The Expression of Glyceraldehyde-3-Phosphate Dehydrogenase Associated Cell Cycle (GACC) Genes Correlates with Cancer Stage and Poor Survival in Patients with Solid Tumors
Dunrui Wang et al.
PLOS ONE (2013)
Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation
Dongning Pan et al.
PLOS ONE (2013)
The Mechanism of Calcium-Induced Inhibition of Muscle Fructose 1,6-bisphosphatase and Destabilization of Glyconeogenic Complex
Dariusz Rakus et al.
PLOS ONE (2013)
Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
Cun Wang et al.
BMC CANCER (2012)
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
Jueng Soo You et al.
CANCER CELL (2012)
Integrative Genomic Analyses of Sporadic Clear Cell Renal Cell Carcinoma Define Disease Subtypes and Potential New Therapeutic Targets
Vijay R. Dondeti et al.
CANCER RESEARCH (2012)
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
Suveera Dhup et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating Glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
Bo Wang et al.
HEPATOLOGY (2012)
Cell cycle-dependent expression and subcellular localization of fructose 1,6-bisphosphatase
Piotr Mamczur et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2012)
Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis
Sarawut Jitrapakdee
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma
George P. Kim et al.
INVESTIGATIONAL NEW DRUGS (2012)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism
Wen Yi et al.
SCIENCE (2012)
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
L. E. Moore et al.
ONCOGENESIS (2012)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
A Hormone-Dependent Module Regulating Energy Balance
Biao Wang et al.
CELL (2011)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
Amparo Wolf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Judith Y. Altarejos et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Upregulated and Downregulated Proteins in Hepatocellular Carcinoma: A Systematic Review of Proteomic Profiling Studies
Zhihua Liu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2011)
Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
Mingquan Chen et al.
PLOS ONE (2011)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Fructose-1,6-Bisphosphatase Regulates Glucose-Stimulated Insulin Secretion of Mouse Pancreatic β-Cells
Ye Zhang et al.
ENDOCRINOLOGY (2010)
Reactive oxygen species, cellular redox systems, and apoptosis
Magdalena L. Circu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
Tony Blick et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Glucose Controls Nuclear Accumulation, Promoter Binding, and Transcriptional Activity of the MondoA-Mlx Heterodimer
Christopher W. Peterson et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Jennifer M. Doyle et al.
MOLECULAR CELL (2010)
Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions
Teresa W-M Fan et al.
METABOLOMICS (2010)
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
X. Liu et al.
ONCOGENE (2010)
Methylation of 12S rRNA Is Necessary for In Vivo Stability of the Small Subunit of the Mammalian Mitochondrial Ribosome
Metodi D. Metodiev et al.
CELL METABOLISM (2009)
Epigenetic Modifiers: Basic Understanding and Clinical Development
Richard L. Piekarz et al.
CLINICAL CANCER RESEARCH (2009)
Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases
Tamer E. Fandy
CURRENT MEDICINAL CHEMISTRY (2009)
The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
M. Cecilia Crisanti et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancer
Marina Bigl et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Fructose-1,6-bisphosphatase overexpression in pancreatic β-cells results in reduced insulin secretion -: A new mechanism for fat-induced impairment of β-cell function
Melkam Kebede et al.
DIABETES (2008)
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats
Taishi Yoshida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes
Qun Dang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1
Dawn M. Z. Schmidt et al.
BIOCHEMISTRY (2007)
Glu 69 is essential for the high sensitivity of muscle fructose-1,6-bisphosphatase inhibition by calcium ions
Marek Zarzycki et al.
FEBS LETTERS (2007)
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
Karim Bensaad et al.
CELL (2006)
Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats
Paul D. van Poelje et al.
DIABETES (2006)
United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action
CL Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
E Metzger et al.
NATURE (2005)
IQGAP1 is a scaffold for mitogen-activated protein kinase signaling
M Roy et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Use of two-dimensional gel electrophoresis in predictive toxicology:: Identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis
K Fella et al.
PROTEOMICS (2005)
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: Head-to-head with a bifunctional enzyme that controls glycolysis
MH Rider et al.
BIOCHEMICAL JOURNAL (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Different sensitivities of mutants and chimeric forms of human muscle and liver fructose-1,6-bisphosphatases towards AMP
D Rakus et al.
BIOLOGICAL CHEMISTRY (2003)
Molecular imaging of cancer with positron emission tomography
SS Gambhir
NATURE REVIEWS CANCER (2002)
Structure and chromosomal localization of the human and mouse muscle fructose-1,6-bisphosphatase genes
H Tillmann et al.
GENE (2000)
Share Paper
